218 related articles for article (PubMed ID: 37209320)
1. Isolation and Characteristics of Extracellular Vesicles Produced by Probiotics: Yeast Saccharomyces boulardii CNCM I-745 and Bacterium Streptococcus salivarius K12.
Kulig K; Kowalik K; Surowiec M; Karnas E; Barczyk-Woznicka O; Zuba-Surma E; Pyza E; Kozik A; Rapala-Kozik M; Karkowska-Kuleta J
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):936-948. PubMed ID: 37209320
[TBL] [Abstract][Full Text] [Related]
2. Exploring Extracellular Vesicles of Probiotic Yeast as Carriers of Biologically Active Molecules Transferred to Human Intestinal Cells.
Mierzejewska J; Kowalska P; Marlicka K; Dworakowska S; Sitkiewicz E; Trzaskowski M; Głuchowska A; Mosieniak G; Milner-Krawczyk M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511103
[TBL] [Abstract][Full Text] [Related]
3. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
[TBL] [Abstract][Full Text] [Related]
4. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
[TBL] [Abstract][Full Text] [Related]
5. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
6. [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
Moré MI
MMW Fortschr Med; 2019 Mar; 161(Suppl 4):20-24. PubMed ID: 30895510
[TBL] [Abstract][Full Text] [Related]
7. Diversity of
Czerucka D; Rampal P
World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Different Probiotic-Derived Extracellular Vesicles as a Novel Adjuvant for Immunotherapy.
Morishita M; Horita M; Higuchi A; Marui M; Katsumi H; Yamamoto A
Mol Pharm; 2021 Mar; 18(3):1080-1092. PubMed ID: 33554596
[TBL] [Abstract][Full Text] [Related]
9. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GA; Harold LK; Tagg JR; Hale JDF
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
[TBL] [Abstract][Full Text] [Related]
10. Probiotic
Wang Y; Li J; Zhang H; Zheng X; Wang J; Jia X; Peng X; Xie Q; Zou J; Zheng L; Li J; Zhou X; Xu X
Front Immunol; 2021; 12():684824. PubMed ID: 34149727
[TBL] [Abstract][Full Text] [Related]
11. Untargeted LC-QTOF-MS/MS based metabolomics approach for revealing bioactive components in probiotic fermented coffee brews.
Chan MZA; Lau H; Lim SY; Li SFY; Liu SQ
Food Res Int; 2021 Nov; 149():110656. PubMed ID: 34600658
[TBL] [Abstract][Full Text] [Related]
12. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of
Maev IV; Andreev DN; Sokolov PS; Fomenko AК; Devkota MK; Andreev NG; Zaborovsky AV
Ter Arkh; 2022 Nov; 94(10):1163-1170. PubMed ID: 36468990
[TBL] [Abstract][Full Text] [Related]
14. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
Chan MZA; Toh M; Liu SQ
Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
[TBL] [Abstract][Full Text] [Related]
15. [Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system].
Stier H; Bischoff SC
MMW Fortschr Med; 2017 Jun; 159(Suppl 5):1-6. PubMed ID: 28643294
[TBL] [Abstract][Full Text] [Related]
16.
Ibáñez L; Pontier-Bres R; Larbret F; Rekima A; Verhasselt V; Blin-Wakkach C; Czerucka D
Front Immunol; 2019; 10():643. PubMed ID: 31001263
[TBL] [Abstract][Full Text] [Related]
17. Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Gopalan S; Ganapathy S; Mitra M; Neha ; Kumar Joshi D; Veligandla KC; Rathod R; Kotak BP
Cureus; 2023 Oct; 15(10):e46314. PubMed ID: 37927652
[TBL] [Abstract][Full Text] [Related]
18. Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GL; Hale JDF; Kemp RA
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1521-1529. PubMed ID: 34282568
[TBL] [Abstract][Full Text] [Related]
19. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin.
Selig DJ; DeLuca JP; Li Q; Lin H; Nguyen K; Scott SM; Sousa JC; Vuong CT; Xie LH; Livezey JR
Drug Metab Pers Ther; 2020 Mar; 35(1):. PubMed ID: 32134728
[TBL] [Abstract][Full Text] [Related]
20. Enhancing probiotic impact: engineering
de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
[No Abstract] [Full Text] [Related]
[Next] [New Search]